REFERENCES
- Chan TM, Lui SL, Li FK, Cheng IK. Fungal peritonitis – Current status 1998. Perit Dial Int. 1999;19(Suppl. 2):S286–S290.
- The Turkish Multicenter Peritoneal Dialysis Study Group (TULIP). The rate, risk factors, and outcome of fungal peritonitis in CAPD patients: Experience in Turkey. Perit Dial Int. 2000;20(3):338–341.
- Samonis G, Gikas A, Anaissie EJ, Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother. 1993;37:51–53.
- Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol. 1998;9:1956–1964.
- Eisenberg ES, Leviton I, Soeiro R. Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature. Rev Infect Dis. 1986;8(3):309–321.
- Lo HK, Chan CK, Shum HP, Chow VC, Mo KL, Wong KS. Risk factors for poor outcome of fungal peritonitis in Chinese patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2003;23(Suppl. 2):S123–S126.
- Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: A single centre Indian experience. J Infect. 2004;48:96–101.
- Goldie SJ, Kiernan-Tridle L, Torres C, Fungal peritonitis in a large chronic peritoneal dialysis population: A report of 55 episodes. Am J Kidney Dis. 1996;28:86–91.
- Piraino B, Bailie GR, Bernardini J, Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25:107–131.
- Lye W-C. Nystatin prophylaxis for fungal peritonitis: To be or not to be? Perit Dial Int. 2007;27:511–513.
- Han SH, Lee SC, Ahn SV, Improving outcome of CAPD: Twenty-five years' experience in a single Korean center. Perit Dial Int. 2007;27(4):432–440.
- Li PK, Law MC, Chow KM, Good patient and technique survival in elderly patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2007;27(Suppl. 2):S196–S201.
- Nakamoto H, Kawaguchi Y, Suzuki H. Is technique survival on peritoneal dialysis better in Japan?. Perit Dial Int. 2006;26(2):136–143.
- Wadhwa NK, Suh H, Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial. 1996;12:189–191.
- Zaruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: Six years' experience. Am J Kidney Dis. 1991;27:43–46.
- Robitaille P, Merouani A, Clermont MJ, Herbert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: A pediatric experience. Perit Dial Int. 1995;15:77–79.
- Lo WK, Chan CY, Cheng SW, Poon JFM, Chan DTM, Cheng IKP. A prospective randomized control study of oral nystatin prophylaxis for Candida peritoneal dialysis. Am J Kidney Dis. 1996;28:549–552.
- Williams PF, Moncrief N, Marriott J. No benefits in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2000;20:352–353.
- Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG. Nystatin prophylaxis: Its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1998;18:583–589.
- Wong PN, Lo KY, Tong GM, Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int. 2007;27(5):531–536.
- Moreiras-Plaza M, Vello-Román A, Sampróm-Rodríguez M, Feijóo-Piñeiro D. Ten years without fungal peritonitis: A single center's experience. Perit Dial Int. 2007;27(4):460–463.
- Debruyme D, Ryckelynck J-P, Moulin M, Hurault deligny B, Levaltier B, Bigot M-C. Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis. Clin Pharmacokinet. 1990;18:491–498.